|
|
||||||||
Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, NY 11040. The Long Island Campus for Albert Einstein College of Medicine, Bronx, NY 10461.
Laboratory data indicate that morphine decreases the number of
peritoneal and alveolar macrophages (M
) and compromises their
phagocytic capability for immune complexes and bacteria. We hypothesize
that morphine decreases the number of, as well as compromises the
phagocytic capability of, M
by programming their death. We studied
the effect of morphine on M
apoptosis in vivo as well as in vitro.
Peritoneal M
harvested from morphine-treated rats showed DNA
fragmentation. Morphine enhanced murine M
(J 774.16) apoptosis in a
dose-dependent manner. Human monocytes treated with morphine showed a
classic ladder pattern in gel electrophoretic and end-labeling studies.
Morphine promoted nitric oxide (NO) production both under basal and
LPS-activated states.
NG-nitro-L-arginine methyl ester
(L-NAME) and
NG-monomethyl-L-arginine
monoacetate (L-NMMA), inhibitors of NO synthase, attenuated
the morphine-induced generation of NO by M
. Morphine also enhanced
M
mRNA expression of inducible NO synthase (iNOS). Since
morphine-induced M
apoptosis was inhibited by L-NAME and L-NMMA, it
appears that morphine-induced M
apoptosis may be mediated through
the generation of NO. Morphine promoted the synthesis of Bax and p53
proteins by M
. Moreover, IL-converting enzyme (ICE)-1 inhibitor
attenuated morphine-induced M
apoptosis. These studies suggest that
morphine activates the induction phase of the apoptotic pathway through
accumulation of p53. The effector phase of morphine-induced apoptosis
appears to proceed through the accumulation of Bax and activation of
ICE-1. The present study provides a basis for a hypothesis that
morphine may be directly compromising immune function by promoting M
apoptosis in patients with opiate addiction.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |